Simplex Trading’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.94M Sell
126,400
-61,400
-33% -$4.28M 0.01% 810
2025
Q4
$12.5M Sell
187,800
-4,900
-3% -$317K 0.01% 733
2025
Q3
$13M Sell
192,700
-137,500
-42% -$10.9M 0.01% 818
2025
Q2
$28.8M Buy
330,200
+117,300
+55% +$9.19M 0.02% 433
2025
Q1
$14.5M Sell
212,900
-128,700
-38% -$10.5M 0.01% 671
2024
Q4
$26.6M Sell
341,600
-26,400
-7% -$1.95M 0.01% 506
2024
Q3
$24.7M Buy
368,000
+17,100
+5% +$1.4M 0.01% 558
2024
Q2
$39.8M Sell
350,900
-70,100
-17% -$8.86M 0.02% 363
2024
Q1
$58.4M Sell
421,000
-215,900
-34% -$27.1M 0.03% 301
2023
Q4
$79M Buy
636,900
+221,200
+53% +$22.6M 0.05% 230
2023
Q3
$38.8M Buy
415,700
+210,100
+102% +$23.7M 0.03% 353
2023
Q2
$26.4M Sell
205,600
-72,900
-26% -$8.82M 0.02% 465
2023
Q1
$32.4M Buy
278,500
+56,500
+25% +$6.32M 0.03% 400
2022
Q4
$25.1M Buy
222,000
+32,200
+17% +$3.54M 0.03% 476
2022
Q3
$15.3M Buy
189,800
+72,000
+61% +$6.1M 0.02% 607
2022
Q2
$8.78M Buy
117,800
+5,800
+5% +$529K 0.01% 858
2022
Q1
$14.3M Sell
112,000
-3,200
-3% -$350K 0.01% 660
2021
Q4
$15.5M Sell
115,200
-59,200
-34% -$8.51M 0.02% 601
2021
Q3
$18.6M Sell
174,400
-3,600
-2% -$454K 0.02% 486
2021
Q2
$19M Buy
178,000
+177,352
+27,369% +$17M 0.02% 463
2021
Q1
$5.82M Sell
648
-920
-59% -$86.4K 0.01% 714
2020
Q4
$14.5M Sell
1,568
-172
-10% -$15.4K 0.02% 444
2020
Q3
$17.9M Buy
1,740
+80
+5% +$8.36K 0.02% 354
2020
Q2
$16.8M Buy
1,660
+1,192
+255% +$107K 0.03% 354
2020
Q1
$3.15M Sell
468
-1,424
-75% -$88.6K 0.01% 956
2019
Q4
$10.3M Buy
1,892
+1,124
+146% +$53.3K 0.02% 452
2019
Q3
$2.87M Buy
768
+312
+68% +$12.1K 0.01% 1053
2019
Q2
$1.71M Sell
456
-428
-48% -$13.5K ﹤0.01% 1431
2019
Q1
$2.63M Buy
884
+488
+123% +$17.1K 0.01% 1134
2018
Q4
$1.19M Sell
396
-1,204
-75% -$38.2K ﹤0.01% 1495
2018
Q3
$5.72M Buy
1,600
+1,356
+556% +$42K 0.02% 559
2018
Q2
$579K Buy
244
+128
+110% +$2.71K ﹤0.01% 2309
2018
Q1
$2K Sell
116
-328
-74% -$4.85K ﹤0.01% 5237
2017
Q4
$35K Sell
444
-196
-31% -$2.55K ﹤0.01% 2765
2017
Q3
$38K Sell
640
-428
-40% -$7.57K ﹤0.01% 2551
2017
Q2
$50K Buy
1,068
+516
+93% +$9.53K ﹤0.01% 2394
2017
Q1
$21K Buy
552
+472
+590% +$9.21K ﹤0.01% 3184
2016
Q4
$13K Sell
80
-108
-57% -$1.91K ﹤0.01% 3457
2016
Q3
$24K Buy
188
+112
+147% +$2.49K ﹤0.01% 2782
2016
Q2
$2K Sell
76
-52
-41% -$885 ﹤0.01% 4903
2016
Q1
$55K Buy
128
+112
+700% +$1.87K ﹤0.01% 1881
2015
Q4
$1K Sell
16
-1,160
-99% -$24.1K ﹤0.01% 4830
2015
Q3
$138K Buy
1,176
+912
+345% +$20.3K 0.01% 1159
2015
Q2
$3K Sell
264
-140
-35% -$2.46K ﹤0.01% 4022
2015
Q1
$18K Buy
404
+248
+159% +$3.75K ﹤0.01% 2414
2014
Q4
$14K Buy
+156
New +$1.91K ﹤0.01% 2318

Other funds holding DXCM

Simplex Trading's DXCM Position: Q1 2026 in Review

Simplex Trading opened a new position in DexCom (DXCM) in Q1 2026: 5,052 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #3768 among its holdings. This is a return to the name: Simplex Trading previously reported a position in DXCM as recently as Q2 2025.

Simplex Trading first reported a position in DXCM in Q1 2015 and has held it in 27 quarters since. The position peaked at $4.41M in Q4 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Simplex Trading held 5,052 shares of DexCom worth $317K as of Q1 2026.
  • DexCom was a new Simplex Trading position in Q1 2026.
  • DexCom made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3768 holding.
  • Simplex Trading first reported a position in DexCom in Q1 2015 and has held it in 27 quarters since.
  • Simplex Trading's DexCom position peaked at $4.41M in Q4 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.